Trial intelligence / Profile preview

Atorvastatin and Pioglitazone in Intermittent Claudication

NCT00153166Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Jan 2004
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of atorvastatin, pioglitazone in intermittent claudication (IC), sponsored by Brigham and Women's Hospital. Started Jan 2004; status: completed.

02

Drugs

atorvastatinpioglitazone
03

Conditions

intermittent claudication (IC)

Beyond the preview

Go deeper on NCT00153166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00153166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call